Benchmark Maintains Buy on DexCom, Raises Price Target to $82
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Benchmark analyst Bruce D. Jackson maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $77 to $82.
Benchmark analyst Bruce D. Jackson maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $77 to $82.